[Guidelines for the diagnosis and treatment of hemophagocytic lymphohistiocytosis (2026 edition)].

What was studied

This is a guideline from China about HLH. HLH is a severe illness caused by a faulty immune system. The fault can be passed down in families or be acquired. A team of 80 experts in China wrote this guideline. They work in blood care, child care, infection care and rheumatology. They reworked the 2022 version using new studies and current evidence.

What they found

This is a guideline, so the abstract gives no study results. The guideline gives 16 points of advice for doctors. These points cover 11 topics. Some topics are how HLH is grouped and how it is diagnosed. Others are lab tests and plans for treatment. It also covers how doctors can judge if treatment works.

What it means for patients

The guideline sets out how doctors in China can find and treat HLH. Its aim is to make care for this disease more uniform. The authors hope it will improve care for people with HLH in China. They also hope it will help patients do better.

Why it is not certain yet

The abstract does not say what each of the 16 points says. It does not say how strong the evidence is for each point. It does not explain how the experts came to agree. This guideline was written for care in China. A guideline can only be as good as the studies it uses.

Source

[Guidelines for the diagnosis and treatment of hemophagocytic lymphohistiocytosis (2026 edition)].

We restate facts from the source record in our own words. The original wording belongs to its publisher.